CareDx

CareDx

Signal active

Investment Firm

Overview

CareDx is a molecular diagnostics company. They offer noninvasive surveillance tests to help identify injuries and rule out rejection. They deliver solutions that support a broad spectrum of needs, from initial matching to post-transplant monitoring and care.

Highlights

Founded

1998

Industry

Information Technology

Employees

501-1000

Investment

1

Lead Investment

1

Exits

1

Stages

Late Stage Venture

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

CareDx, established in 1998 and headquartered in United States, North America., specializes in Late Stage Venture investments across Biotechnology, Health Care, Medical, Medical Device. Their recent investments include Miromatrix Medical. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Sean Grant

Sean Grant

Vice President, Corporate Strategy & Business Development

imagePlace Marica Grskovic

Marica Grskovic

Head of Cell Transplant Therapy

imagePlace Michelle Foley

Michelle Foley

VP Transplant Software Operations

imagePlace Reginald Seeto

Reginald Seeto

Founder, President & CEO

imagePlace Pauline Callinan

Pauline Callinan

Vice President Of Business Development

imagePlace John Hanna

John Hanna

President and CEO

Investment portfolio

N/A

investments

1

Diversity investments

1

Lead investments

1

Number of exits

1

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
May 28, 2021
Miromatrix Medical Miromatrix Medical
Biotechnologynull

Exits

1

Funding Timeline

Funding rounds

1

Investors

15

Funds

0

Funding Rounds

1

CareDx has raised 1 rounds. Their latest funding was raised on May 28, 2021 from a Series C - Miromatrix Medical round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
May 28, 2021
Series C - Miromatrix Medical Series C - Miromatrix Medical
-0-

Investors

39

CareDx is funded by 39 investor(s). Armentum Partners and Silicon Valley Bank Kantor are the most recent investors.

Investor NameLead InvestorFunding RoundMoney Raised
-No
Post-IPO Equity - CareDx
18.3M
-No
Post-IPO Equity - CareDx
52.8M
-No
Post-IPO Equity - CareDx
117.1M
-No
Post-IPO Equity - CareDx
164.0M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.